Prodrugs in site-selective delivery of radiopharmaceuticals

Quarterly Journal of Nuclear Medicine

Volumn 41, Issue 2, 1997, Pages 127-139

  Baranowska Kortylewicz, J ^a   Kortylewicz, Z P ^a   Hoffman, D ^a   Dalrymple, G V ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Prodrugs; Radiopharmaceuticals; Site specific delivery; Tumor targeting

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IDOXURIDINE DERIVATIVE; IDOXURIDINE I 125; NITROIMIDAZOLE DERIVATIVE; PHENETHYLAMINE DERIVATIVE; PRODRUG; RADIOPHARMACEUTICAL AGENT; RHODAMINE 123; UNCLASSIFIED DRUG;

ARTICLE; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG LIVER LEVEL; DRUG PENETRATION; DRUG SPECIFICITY; DRUG TARGETING; ISOTOPE LABELING; ORAL DRUG ADMINISTRATION; OVARY CANCER; RADIODIAGNOSIS;

ANIMALS; HUMANS; IDOXURIDINE; IODINE RADIOISOTOPES; NEOPLASMS; PRODRUGS; RADIOPHARMACEUTICALS;

EID: 0030964835     PISSN: 11243937     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)